433 related articles for article (PubMed ID: 6163587)
1. Raynaud's phenomenon and scleroderma.
Harper FE; LeRoy EC
Compr Ther; 1981 Feb; 7(2):45-51. PubMed ID: 6163587
[No Abstract] [Full Text] [Related]
2. [The sclerodermas].
Huriez C
Lille Med; 1971 Dec; 16(10):1358-69. PubMed ID: 5160880
[No Abstract] [Full Text] [Related]
3. Progressive systemic sclerosis (scleroderma).
JAMA; 1973 Apr; 224(5 Suppl):711-6. PubMed ID: 4739736
[No Abstract] [Full Text] [Related]
4. Scleroderma and related disorders: therapeutic aspects.
Denton CP; Black CM
Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):17-35. PubMed ID: 10882212
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis (scleroderma). Clinical management of its major complications.
Legerton CW; Smith EA; Silver RM
Rheum Dis Clin North Am; 1995 Feb; 21(1):203-16. PubMed ID: 7732169
[TBL] [Abstract][Full Text] [Related]
6. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment.
Kumar N; Griffiths B; Allen J
J Rheumatol; 2006 Sep; 33(9):1918-9. PubMed ID: 16960964
[No Abstract] [Full Text] [Related]
7. [Scleroderma and its visceral complications].
Huriez C
Maroc Med; 1972 Jun; 52(558):331-44. PubMed ID: 4636029
[No Abstract] [Full Text] [Related]
8. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis.
Herrick AL; Cutolo M
Arthritis Rheum; 2010 Sep; 62(9):2595-604. PubMed ID: 20506306
[No Abstract] [Full Text] [Related]
9. [Systemic scleroderma in children].
Plantin P; Gavanou J; Le Fur JM; Guillet G
Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis/scleroderma: a treatable multisystem disease.
Hinchcliff M; Varga J
Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
[TBL] [Abstract][Full Text] [Related]
11. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends].
Zelli GP; Cannata P
Ann Ital Chir; 1981; 53(3):337-43. PubMed ID: 7337317
[No Abstract] [Full Text] [Related]
12. [Raynaud's syndrome and scleroderma. I. Scleroderma-like changes in Raynaud's syndrome and their differentiation from scleroderma].
JABLONSKA S; LUKASIAK B; BUBNOW B
Pol Tyg Lek (Wars); 1957 Sep; 12(39):1481-6. PubMed ID: 13505250
[No Abstract] [Full Text] [Related]
13. Systemic sclerosis.
Ng SC
Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
[TBL] [Abstract][Full Text] [Related]
14. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
15. [Systemic scleroderma].
Rommel A
Sem Hop; 1984 Mar; 60(10):710-24. PubMed ID: 6322321
[TBL] [Abstract][Full Text] [Related]
16. Beyond Raynaud's phenomenon hides very early systemic sclerosis: the assessment of organ involvement is always mandatory.
Czirják L; Matucci-Cerinic M
Rheumatology (Oxford); 2011 Feb; 50(2):250-1. PubMed ID: 21115465
[No Abstract] [Full Text] [Related]
17. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
Henness S; Wigley FM
Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
[TBL] [Abstract][Full Text] [Related]
18. [The use of Capoten in systemic scleroderma].
Guseva NG; Anikina NV; Shcherbakov AB
Ter Arkh; 1992; 64(5):100-2. PubMed ID: 1455361
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations of systemic sclerosis.
Steen VD
Semin Cutan Med Surg; 1998 Mar; 17(1):48-54. PubMed ID: 9512107
[TBL] [Abstract][Full Text] [Related]
20. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
LeRoy EC
Curr Opin Rheumatol; 1992 Dec; 4(6):821-4. PubMed ID: 1457276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
